Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.390
+0.010 (0.72%)
At close: Mar 9, 2026, 4:00 PM EDT
1.390
0.00 (-0.02%)
After-hours: Mar 9, 2026, 7:49 PM EDT

PACB Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4205392,6271,853452499
Market Cap Growth
-6.53%-79.49%41.76%309.80%-9.36%533.79%
Enterprise Value
842.69588.442,6511,883498.87579.47
Last Close Price
1.391.839.818.1820.4625.94
PE Ratio
--1.15-8.11-5.84-22.99152.59
PS Ratio
2.6246.06217.81145.3038.3744.68
PB Ratio
78.47-9.61-132.07-83.22-12.89-7.94
P/TBV Ratio
-7.15-9.42-125.11-82.50-119.09-72.26
P/FCF Ratio
--21.81-63.70-37.60-9.43-9.64
P/OCF Ratio
--22.27-65.34-38.02-9.55-9.90
EV/Sales Ratio
5.2750.30219.84147.6542.3451.90
EV/EBITDA Ratio
--18.45-52.21-31.48-7.23-9.55
EV/EBIT Ratio
--16.66-49.07-29.98-6.97-9.10
EV/FCF Ratio
--23.82-64.30-38.21-10.41-11.20
Debt / Equity Ratio
-1.18-1.18-1.89-3.40-3.15-2.37
Debt / EBITDA Ratio
-2.09-2.09-0.77-1.30-1.61-2.47
Debt / FCF Ratio
-2.69-2.69-0.95-1.57-2.32-2.90
Net Debt / Equity Ratio
-0.90-0.90-1.31-1.44-1.35-1.30
Net Debt / EBITDA Ratio
-1.58-1.58-0.51-0.53-0.69-1.35
Net Debt / FCF Ratio
-2.03-2.03-0.63-0.65-0.99-1.58
Asset Turnover
0.390.390.250.170.130.10
Inventory Turnover
2.922.922.241.841.700.78
Quick Ratio
0.590.591.320.729.4910.02
Current Ratio
0.710.712.030.8410.5611.76
Return on Equity (ROE)
131.82%131.82%292.36%217.99%158.77%222.84%
Return on Assets (ROA)
-117.70%-117.70%-113.68%-84.73%-81.15%-55.92%
Return on Invested Capital (ROIC)
-491.89%-491.89%-503.92%-492.31%-430.08%-334.01%
Return on Capital Employed (ROCE)
-423.20%-423.20%-607.40%-168.47%-88.04%-59.89%
Earnings Yield
-130.16%-86.89%-12.33%-17.11%-4.35%0.66%
FCF Yield
-27.14%-4.58%-1.57%-2.66%-10.60%-10.38%
Buyback Yield / Dilution
-2.88%-2.88%-0.15%-1.79%-9.91%-1.29%
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q